JenaValve Technology

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Irruptive Metals (TSXV: IRR) upsizes Pimentón financing to C$50m

Metals One (AIM: MET1) targets first Barbrook gold within six months

Trellidor (JSE: TRL) swings to headline loss as UK project boost disappears

RailTel (NSE: RAILTEL) wins Rs 164.78cr WCL deal as shares climb

Representative image illustrating U.S. antitrust scrutiny in the medical device sector, as a federal court blocks Edwards Lifesciences Corporation’s proposed acquisition of JenaValve Technology, reinforcing tougher regulatory oversight of healthcare mergers.

US FTC blocks Edwards Lifesciences acquisition of JenaValve in decisive antitrust win for medical device competition

FTC blocks Edwards Lifesciences Corporation’s JenaValve deal, reshaping medtech M&A and signaling tougher scrutiny of innovation driven acquisitions. Read more.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynyz
ZYNRELEF
Zynga

January 10, 2026